LBRXLB Pharmaceuticals Inc Common Stock
47.62USD-2.70%Mkt Cap: 1.54B $P/E: —3d ago
LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small mole…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap1.54B $
Enterprise Value1.20B $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-25.20M $
Revenue/Share—
Last Price47.62 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees49
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-9.54
PEG—
EV/EBITDA-13.19
EV/Revenue—
P/S—
P/B4.08
EPS (TTM)-4.93
EPS (Forward)-4.95
52W Range
13.3694% of range49.97
52W High49.97 USD
52W Low13.36 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-8.37%
ROA-8.05%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-35.21M $
CapEx (TTM)52.00K $
FCF Margin—
FCF Yield-3.51%
Net Debt-322.57M $
Net Debt/EBITDA3.54
Balance Sheet
Debt/Equity0.01
Current Ratio15.08
Quick Ratio13.91
Book Value/Sh11.59 USD
Cash/Share10.16 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)51.50 USD
Upside (mean)+8.1%
Target Range37.00 USD – 78.00 USD
$37.00+8.1% to mean$78.00
# Analysts8
Ownership
Shares Out.32.26M
Float26.46M
Insiders0.24%
Institutions101.33%
Short Interest
Short Ratio14.9d
Short % Float19.92%
Short % Out.16.55%
Shares Short4.75M
Short (prev mo.)4.55M
Technical
SMA 5036.40 (+30.8%)
SMA 20026.91 (+77.0%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)340.29K
Avg Vol (10d)317.39K
Technical Indicators
RSI (14)65.1
MACD3.4114
MACD Signal3.5047
MACD Hist.-0.0933
BB Upper52.88 USD
BB Middle44.31 USD
BB Lower35.73 USD
BB Width38.70%
ATR (14)2.608 USD
Vol Ratio (20d)0.58x